Home › Selling an ABA Therapy Business in 2026

Selling an ABA Therapy Business in 2026

Quick Answer

An ABA (applied behavior analysis) therapy business serving children with autism in 2026 typically sells for 6x EBITDA at the small end up to the low teens for scaled, well-run multi-site platforms. The biggest value drivers are scale (a multi-site operation with a real management layer and $1M-$5M+ EBITDA is worth far more per dollar than a single-clinic practice), payer mix and billing quality (a healthy blend of commercial and Medicaid with clean claims, low denial rates, defensible authorization and documentation practices), BCBA and RBT recruitment and retention (clinician supply is the binding constraint, so a recruiting engine and low turnover are premium), and a management infrastructure (intake, authorization, scheduling, billing, credentialing) that runs without the founding clinician. Active buyers include PE-backed autism/ABA platforms (multiple new platforms have formed recently), larger ABA companies acquiring for geography and capacity, health systems, and payers building care delivery. Several buyers in CT’s network have stated mandates for autism, ABA, and intellectual and developmental disability services. Most ABA business sales close in 90 to 180 days.

ABA therapy has been one of the most actively consolidated corners of healthcare, autism diagnoses keep rising, most states mandate commercial coverage, Medicaid funds a large share of services, and private equity has built platform after platform. Transaction volume has stayed high, with new PE platforms forming and existing platforms doing steady tuck-ins. But the difference between what a single clinic fetches and what a scaled, well-managed multi-site ABA platform fetches is enormous. This guide covers the multiples, the payer-mix and BCBA-retention math, the PE-backed buyers, what kills deals in diligence, and the process.

We are CT Acquisitions, a buy-side M&A advisory firm with buyers in our network actively acquiring ABA therapy and autism services businesses (several with mandates specifically for autism, ABA, and IDD services). Sellers pay nothing, the buyer pays our fee at closing. See also our guides on selling a behavioral health practice, selling a home health agency, and healthcare business valuation.

Free Valuation Tool → Book a 30-Min Call Read: Broker Alternative

What this guide covers

Single-clinic / small ABA practice: typically 4x to 6x SDE/EBITDA (clinician-dependent, hard to scale)
Multi-site ABA business with a management layer ($1M-$5M EBITDA): 6x to 9x EBITDA
Scaled ABA platform ($5M+ EBITDA, multi-state, de novo-capable): low double digits, up to the low teens on EBITDA
Biggest value drivers: scale, payer mix and billing quality (clean commercial + Medicaid claims, defensible authorization/documentation), BCBA/RBT recruitment and retention, and a management infrastructure independent of the founder
Active buyers: PE-backed autism/ABA platforms, larger ABA companies, health systems, payers building care delivery; we have buyers in our network (several with autism/ABA/IDD mandates)
Free valuation: our 90-second tool applies ABA-specific adjustments for scale, payer mix, clinician retention, and management depth

What ABA therapy business buyers actually pay for in 2026

Single-clinic or small ABA practice

Typical multiples: 4x to 6x SDE/EBITDA. One location, a small BCBA/RBT team, revenue tied to the founding clinician’s caseload and the local payer relationships. Buyer pool: larger regional ABA companies doing tuck-ins, individual BCBA-owner buyers, smaller platforms. Multiples reach the upper end when there is a stable clinician team beyond the owner, clean billing, a workable payer mix, and a smooth transition.

Multi-site ABA business with a management layer

Typical multiples: 6x to 9x EBITDA in the $1M-$5M EBITDA range. Several clinics, a roster of BCBAs and RBTs, intake/authorization/billing infrastructure, and a payer mix that holds up. PE-backed ABA platforms, larger ABA companies, and occasionally health systems compete here. Multiples reach the upper end when EBITDA is $3M+, the payer mix is balanced, clinician turnover is low with an active recruiting pipeline, documentation and authorization practices are clean, and the management team stays.

Scaled ABA platform

Typical multiples: low double digits, up to the low teens on EBITDA. Multi-state operations ($5M+ EBITDA), de novo-clinic-capable, with strong payer relationships, a deep clinical and operations bench, and demonstrated organic growth, command the top of the range, driven by payer and health-system demand for capacity and the scarcity of well-run scaled ABA assets.

The payer-mix and BCBA-retention math

Factor	Why it moves the multiple
Balanced commercial + Medicaid payer mix	Commercial pays better per hour; Medicaid funds large, sticky volume; a healthy blend is more durable than over-reliance on either
Clean billing, low denials, defensible authorization and documentation practices	ABA billing is heavily authorization-driven and audit-prone; clean claims and documentation are the single biggest diligence factor
Strong payer contracts and credentialing across locations	Revenue you can actually collect, in markets you can actually grow; credentialing gaps slow or kill expansion theses
BCBA and RBT recruiting engine + low turnover	Clinician supply is THE constraint in ABA; a business that can hire and keep BCBAs/RBTs is a growth platform, not just a book
Healthy clinician productivity / billable utilization	Drives EBITDA margin and signals operational discipline
Management infrastructure (intake, authorization, scheduling, billing, HR, credentialing) independent of the founder	The business runs without the founding clinician; buyer isn’t buying a job
Waitlist / unmet demand in served markets	Built-in organic growth runway the buyer can capture by adding capacity

The pattern is the same as broader behavioral health: ABA value is about whether the business is a scalable, well-run, payer-diversified, compliant care delivery organization with a clinician-recruiting engine, or a single-clinic clinician-dependent book. Move toward the former and the multiple moves with you.

The PE-backed platforms buying ABA therapy businesses in 2026

PE-backed autism / ABA platforms, private equity has built numerous ABA platforms over the past several years and continues to form new ones; transaction volume has stayed high, with platforms doing steady tuck-in acquisitions of multi-site and single-clinic businesses and acquiring larger groups as new platforms.
Larger ABA companies, acquiring for geographic expansion, clinic density, and clinician capacity.
Health systems and pediatric-services platforms, adding autism/ABA capability to a broader pediatric or behavioral health offering.
Payers and managed care organizations, building or buying ABA delivery to manage access and cost for their members.
Regional groups and individual BCBA-owner buyers, for smaller practices.

Note: several buyers in CT’s network have explicit mandates for autism, ABA, and intellectual and developmental disability services (some specifically non-physician-led healthcare services), this is a vertical where we have active demand.

We have buyers for ABA therapy and autism services businesses. CT works with a network of 100+ active capital partners, private equity firms, family offices, strategic acquirers, and search funders, and several of them have stated mandates to acquire ABA therapy and autism services businesses. The multiples, buyer types, and dynamics on this page reflect those mandates plus current public M&A data, they are informed starting points, not guarantees; your outcome depends on the specifics. With the buyer-paid model, sellers pay no advisory fee, the buyer pays at closing. Get a sector-adjusted estimate with our free 90-second valuation tool.

How to prepare an ABA therapy business for sale

Clean up billing, authorization, and documentation. Reduce denials and AR aging, make sure treatment plans, authorizations, and session notes are defensible, fix credentialing gaps. ABA is audit-prone, this is the biggest diligence area, fix it before you list.
Reduce founder-clinician dependency. Build clinical leadership below the owner (clinical director, regional BCBAs), transition oversight, and put operations leadership in place.
Document and balance the payer mix. Show the commercial/Medicaid breakdown, contracts, and rates by payer; diversify away from over-reliance on a single payer.
Build a BCBA/RBT recruiting pipeline and reduce turnover, document your hiring funnel, ramp time, retention, and clinician productivity. This is a major value lever.
Show your waitlist / unmet demand by market, it’s the buyer’s organic growth case.
Tighten operations metrics, billable hours per clinician, authorization-to-service conversion, no-show/cancellation rates, intake-to-treatment timelines.
Clean financials, accrual accounting, normalized owner comp, documented add-backs, 2-3 year review, and clear unit economics by clinic.

What kills ABA therapy business deals in diligence

Billing, authorization, and documentation problems, denials, aged AR, weak treatment-plan or session-note documentation, audit exposure
Credentialing gaps that block expansion or create revenue risk
Founder-clinician dependency, the clinical oversight and payer relationships run through one person
BCBA/RBT turnover or a thin clinician bench with no recruiting pipeline
Payer concentration or over-reliance on a single Medicaid plan or commercial payer
Low billable utilization or unclear clinic-level unit economics
Compliance flags, billing-for-services-not-rendered exposure, supervision-ratio issues
Sloppy financials that don’t normalize owner comp or show clinic-level economics

The process: first conversation to close

Off-market to a PE-backed ABA platform, larger ABA company, health system, or payer: roughly 90-180 days, days 1-14 conversation/valuation/fit, days 14-30 buyer introductions, days 30-60 LOI, days 60-150 diligence (financials, billing/authorization/documentation review, payer-contract and credentialing analysis, clinician roster and retention, compliance, corporate structure) and definitive agreement, days 120-180 close and transition. Traditional broker listings take 9-18 months. See our broker alternative guide.

ABA Therapy Business Valuation

What’s your ABA therapy business worth?

Get a sector-adjusted multiple range using current 2026 transactions. We apply ABA-specific adjustments for scale, payer mix, billing/documentation quality, clinician retention, and management depth.

Get an ABA Business Valuation →

The five pillars of how CT Acquisitions works

$0 to Sellers

Buyer pays our fee. Founders never write a check.

No Retainer

No engagement letter. No upfront cost. No exclusivity contract.

100+ Capital Partners

Search funders, family offices, lower-middle-market PE, strategics.

Sequential, Not Auction

Confidential introductions to the right buyers. No bidding war.

60-120 Day Close

Not 9-12 months. Not 18 months. Months, not years.

No Pitch · No Pressure

Considering selling your ABA therapy business?

Tell us about your business, clinics, BCBA/RBT roster, payer mix, EBITDA, management structure. We have buyers actively acquiring ABA therapy businesses (several with autism/ABA/IDD mandates), and we’ll discuss what yours is worth and which buyers fit. No engagement letter, no retainer, no obligation.

Start a Confidential Conversation →

Frequently asked questions

How much is my ABA therapy business worth?

Single-clinic or small ABA practices typically sell for 4x to 6x SDE/EBITDA, because revenue is clinician-dependent. Multi-site ABA businesses with a management layer (roughly $1M-$5M EBITDA) sell for 6x to 9x EBITDA. Scaled ABA platforms (multi-state, $5M+ EBITDA, de novo-capable) reach the low double digits, up to the low teens on EBITDA. The biggest multiple drivers are scale, payer mix and billing/authorization/documentation quality, BCBA and RBT recruitment and retention, and a management infrastructure independent of the founding clinician. Use our free valuation tool for a sector-adjusted estimate.

What makes an ABA therapy business more valuable?

Scale (more clinics, more clinicians beyond the owner, more EBITDA, valued at a higher multiple per dollar); a balanced commercial + Medicaid payer mix with clean billing, low denials, and defensible authorization and documentation practices; strong payer contracts and credentialing across locations; a BCBA/RBT recruiting engine and low turnover (clinician supply is the binding constraint); healthy billable utilization; a management infrastructure (intake, authorization, scheduling, billing, credentialing) that runs without the founder; a visible waitlist of unmet demand; and clean accrual financials with normalized owner comp and clinic-level unit economics. The billing/documentation cleanup and reducing founder dependency are the biggest levers.

Who is buying ABA therapy businesses in 2026?

PE-backed autism/ABA platforms (private equity has built numerous ABA platforms and continues forming new ones; transaction volume has stayed high with steady tuck-in activity); larger ABA companies expanding geography and clinic density; health systems and pediatric-services platforms adding autism/ABA capability; payers and managed care organizations building or buying ABA delivery; and regional groups and individual BCBA-owner buyers for smaller practices. CT also has buyers in its network with explicit mandates for autism, ABA, and intellectual and developmental disability services.

Why is ABA M&A so active?

Autism diagnoses keep rising, most states mandate commercial coverage of ABA, Medicaid funds a large share of services, and demand for ABA vastly exceeds the supply of BCBAs and RBTs. That structural demand, plus payer and health-system pressure to expand access, plus private equity’s appetite for fragmented healthcare-services rollups, has kept ABA transaction volume high for years, with new platforms forming and existing platforms doing steady tuck-ins. Multiples for scaled, well-run platforms reach the low teens; smaller clinician-dependent practices get less, but the sector overall trades well above generic small-business multiples.

How does my payer mix and billing affect what my ABA business is worth?

A lot. Buyers want collectible, durable revenue. A balanced commercial-plus-Medicaid mix, with clean claims, low denial rates, and defensible authorization and documentation practices, is far more valuable than a business with billing problems or heavy reliance on a single payer. ABA billing is authorization-driven and audit-prone, so documentation quality (treatment plans, authorizations, session notes, supervision ratios) is the single biggest diligence factor; weak documentation gets deals repriced or killed. Clean it up before you go to market and present clear payer-mix, denial, and AR-aging metrics.

How do I increase the value of my ABA therapy business?

Clean up billing, authorization, and documentation (the biggest diligence area, reduce denials and AR aging, make treatment plans/authorizations/session notes defensible, fix credentialing); reduce founder-clinician dependency (build clinical leadership below the owner, install operations leadership); document and balance the payer mix; build a BCBA/RBT recruiting pipeline and lower turnover; surface your waitlist of unmet demand; tighten operational metrics (billable utilization, intake-to-treatment timelines); and get clean accrual financials with normalized owner comp and clinic-level unit economics. The billing cleanup and founder-dependency reduction can be materially improved in 12-24 months.

How long does it take to sell an ABA therapy business?

Traditional broker-listed ABA businesses typically take 9-18 months. Off-market sales to PE-backed ABA platforms, larger ABA companies, health systems, or payers typically take 90-180 days, because the buyer is pre-qualified and actively looking to acquire in your geography, size range, and payer footprint, and ABA diligence (financials, billing/authorization/documentation, payer contracts and credentialing, clinician roster, compliance, corporate structure) is well-trodden ground for these buyers.

Do I need a broker to sell my ABA therapy business?

For a single clinic, a healthcare-focused business broker can work but charges 8-15% commissions. For multi-site ABA businesses, a buyer-paid sell-side advisor with relationships across the PE-backed ABA platforms, larger ABA companies, health systems, and payers usually produces better outcomes, higher multiples, better-matched buyers, faster close, no seller fee (the buyer pays at closing). Some sellers sell directly to a known platform with just healthcare transactional counsel, but a competitive process almost always lifts the price, especially given how many active ABA acquirers there are.